de Bruijn KM - Search Results

1

Prophylaxis with ranitidine against peptic ulcer disease after liver transplantation.

Klompmaker IJ, Slooff MJ, de Bruijn KM, Sluiter WJ, Bams JL. Klompmaker IJ, et al. Among authors: de bruijn km. Transpl Int. 1988 Dec;1(4):209-12. doi: 10.1111/j.1432-2277.1988.tb01818.x. Transpl Int. 1988. PMID: 3075484 Clinical Trial.

2

Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome.

Klompmaker IJ, Sloof MJ, van der Meer J, de Jong GM, de Bruijn KM, Bams JL. Klompmaker IJ, et al. Among authors: de jong gm, de bruijn km. Transplantation. 1989 Jul;48(1):149-51. doi: 10.1097/00007890-198907000-00035. Transplantation. 1989. PMID: 2501918 No abstract available.

3

Mortality after orthotopic liver transplantation. An analysis of the causes of death in the first 50 liver transplantations in Groningen, The Netherlands.

Slooff MJ, Klompmaker IJ, Grond J, De Bruijn KM, Verwer R, Hesselink EJ, Haagsma EB. Slooff MJ, et al. Among authors: de bruijn km. Transpl Int. 1988 Jul;1(2):69-74. Transpl Int. 1988. PMID: 3076383

4

Cyclosporine neurotoxicity late after liver transplantation.

de Bruijn KM, Klompmaker IJ, Slooff MJ, Fockens P, Hillen PH. de Bruijn KM, et al. Transplantation. 1989 Mar;47(3):575-6. Transplantation. 1989. PMID: 2646790 No abstract available.

5

Donor data in liver grafts with primary non-function--a preliminary analysis by the European Liver Registry.

Pruim J, van Woerden WF, Knol E, Klompmaker IJ, de Bruijn KM, Persijn GG, Slooff MJ. Pruim J, et al. Among authors: de bruijn km. Transplant Proc. 1989 Feb;21(1 Pt 2):2383-4. Transplant Proc. 1989. PMID: 2652776 No abstract available.

6

Recurrence of hepatocellular carcinoma after liver retransplantation.

Klompmaker IJ, de Bruijn KM, Gouw AH, Bams JI, Slooff MJ. Klompmaker IJ, et al. Among authors: de bruijn km. Br Med J (Clin Res Ed). 1988 May 21;296(6634):1445. doi: 10.1136/bmj.296.6634.1445. Br Med J (Clin Res Ed). 1988. PMID: 2837306 Free PMC article. No abstract available.

7

The validity of clinical parameters for the selection of liver donors.

Pruim J, Hesselink EJ, de Vos R, Klompmaker IJ, de Bruijn KM, Grond J, van Goor H, Slooff MJ. Pruim J, et al. Among authors: de vos r, de bruijn km. Transplant Proc. 1988 Oct;20(5):973. Transplant Proc. 1988. PMID: 3055544 No abstract available.

8

A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.

Wymenga AN, van der Graaf WT, Wils JA, Siegenbeek van Heukelom L, van der Linden GH, Dullemond-Westland AC, Nooy M, van der Heul C, de Bruijn KM, de Vries EG. Wymenga AN, et al. Among authors: de bruijn km. Ann Oncol. 1996 Jul;7(5):505-10. doi: 10.1093/oxfordjournals.annonc.a010640. Ann Oncol. 1996. PMID: 8839906 Free article. Clinical Trial.

9

Pancreatic and duodenal ammonia in dogs: lowering by glucose infusion.

de Bruijn KM, Gips CH. de Bruijn KM, et al. Int J Pancreatol. 1986 Dec;1(5-6):353-62. doi: 10.1007/BF02801867. Int J Pancreatol. 1986. PMID: 3316428

10

The development of tropisetron in its clinical perspective.

de Bruijn KM. de Bruijn KM. Ann Oncol. 1993;4 Suppl 3:19-23. doi: 10.1093/annonc/4.suppl_3.s19. Ann Oncol. 1993. PMID: 8363994 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters